Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic

INTRODUCTION: The COVID-19 pandemic has disrupted healthcare services, reducing opportunities to conduct routine hepatitis C virus antibody screening, clinical care, and treatment. Therefore, people living with undiagnosed hepatitis C virus during the pandemic may later become identified at more adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufman, Harvey W., Bull-Otterson, Lara, Meyer, William A., Huang, Xiaohua, Doshani, Mona, Thompson, William W., Osinubi, Ademola, Khan, Mohammed A., Harris, Aaron M., Gupta, Neil, Van Handel, Michelle, Wester, Carolyn, Mermin, Jonathan, Nelson, Noele P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal of Preventive Medicine. Published by Elsevier Inc. 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107198/
https://www.ncbi.nlm.nih.gov/pubmed/34088556
http://dx.doi.org/10.1016/j.amepre.2021.03.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107198/
https://www.ncbi.nlm.nih.gov/pubmed/34088556
http://dx.doi.org/10.1016/j.amepre.2021.03.011

Ejemplares similares